Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,229 public trials 1,177 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

NCT06449209

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +9 more
Locations
  • Alaska Oncology and Hematology, LLC Anchorage, Alaska, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Clermont Oncology Center Clermont, Florida, United States
  • Hematology Oncology Associates of Treasure Coast Port Saint Lucie, Florida, United States
View all 64 locations
View Trial Details
Active, Not Recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

NCT05633602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)

NCT06049212

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Aichi Cancer Center ( Site 0006) Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East ( Site 0002) Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 0008) Matsuyama, Ehime, Japan
  • Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan
View Trial Details
Active, Not Recruiting

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

NCT05635708

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center Mskcc New York, United States
  • Providence Portland Medical Center Portland, Oregon, United States
View all 61 locations
View Trial Details

Related conditions